Designs for Single- or Multiple-Agent Phase I Trials (Q3445286): Difference between revisions

From MaRDI portal
Added link to MaRDI item.
Import241208061232 (talk | contribs)
Normalize DOI.
 
(4 intermediate revisions by 4 users not shown)
Property / DOI
 
Property / DOI: 10.1111/j.0006-341X.2004.00215.x / rank
Normal rank
 
Property / Wikidata QID
 
Property / Wikidata QID: Q30434355 / rank
 
Normal rank
Property / MaRDI profile type
 
Property / MaRDI profile type: MaRDI publication profile / rank
 
Normal rank
Property / cites work
 
Property / cites work: A Random Walk Rule for Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Confidence interval estimation subject to order restrictions / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Likelihood Approach / rank
 
Normal rank
Property / cites work
 
Property / cites work: Continual Reassessment Method: A Practical Design for Phase 1 Clinical Trials in Cancer / rank
 
Normal rank
Property / cites work
 
Property / cites work: Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Design and Analysis of Phase I Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose Finding Using the Biased Coin Up-and-Down Design and Isotonic Regression / rank
 
Normal rank
Property / cites work
 
Property / cites work: Practical Bayesian Guidelines for Phase IIB Clinical Trials / rank
 
Normal rank
Property / cites work
 
Property / cites work: Dose-Finding with Two Agents in Phase I Oncology Trials / rank
 
Normal rank
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1111/j.0006-341x.2004.00215.x / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W2046121575 / rank
 
Normal rank
Property / DOI
 
Property / DOI: 10.1111/J.0006-341X.2004.00215.X / rank
 
Normal rank

Latest revision as of 07:39, 21 December 2024

scientific article
Language Label Description Also known as
English
Designs for Single- or Multiple-Agent Phase I Trials
scientific article

    Statements

    Identifiers